ARAH Stock Overview Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. More details
Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
Aleafia Health Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for Aleafia Health Historical stock prices Current Share Price CA$0.015 52 Week High CA$0.079 52 Week Low CA$0.0005 Beta 1.73 1 Month Change 0% 3 Month Change 3,000.00% 1 Year Change -50.79% 3 Year Change -94.60% 5 Year Change -97.67% Change since IPO -96.70%
Recent News & Updates
Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million. Jan 16
Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million. Jan 15
Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc. Oct 13
Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process Jul 26
New major risk - Financial position Jun 16
Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022) Jun 15 See more updates
Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million. Jan 16
Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million. Jan 15
Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc. Oct 13
Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process Jul 26
New major risk - Financial position Jun 16
Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022) Jun 15
Red White & Bloom Brands Inc. (CNSX:RWB) entered into a binding letter agreement to acquire Aleafia Health Inc. (TSX:AH) from shareholders for CAD 74.98 million. Jun 09
High number of new and inexperienced directors Apr 11
Third quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.22 loss in 3Q 2022) Feb 14
Aleafia Health Inc. to Report Q3, 2023 Results on Feb 08, 2023 Feb 02
Now 33% undervalued Feb 02
Aleafia Health Inc. Announces Board Changes Jan 31
Now 36% undervalued after recent price drop Jan 05
High number of new and inexperienced directors Jan 04
High number of new and inexperienced directors Nov 16
Aleafia Health Inc. to Report Q2, 2023 Results on Nov 09, 2022 Nov 03
Aleafia Health Expands Sunday Market House of Brands with Coveted Lineup of Winter Product Launches Nov 02
Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022 Sep 17
Aleafia Health Inc. to Report Q2, 2022 Results on Aug 11, 2022 Aug 05
Aleafia Health Inc., Annual General Meeting, Sep 27, 2022 Jul 22
High number of new and inexperienced directors Jul 21
Full year 2022 earnings released: CA$0.42 loss per share (vs CA$0.84 loss in FY 2021) Jun 29
Aleafia Health Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023 Jun 29 Aleafia Health Inc. announced that it has received CAD 5.6225 million in funding Jun 25
High number of new and inexperienced directors Jun 14 Aleafia Health Inc. announced that it expects to receive CAD 5.6225 million in funding May 13
High number of new and inexperienced directors Apr 27
Aleafia Health Inc. Reaffirms Earnings Guidance for the Fiscal Year 2022 Apr 06
Aleafia Health Inc. Announces Impairment of Property, Plant & Equipment for the Fourth Quarter Ended December 31, 2021 Feb 17
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Feb 16 Aleafia Health Inc. to Report Q4, 2021 Results on Feb 14, 2022
Aleafia Health Inc. Announces Executive Changes Feb 08
Third quarter 2021 earnings released: CA$0.25 loss per share (vs CA$0.066 loss in 3Q 2020) Nov 12
High number of new and inexperienced directors Sep 28
Aleafia Health Launches Premium Cannabis Brand Nith & Grand Jul 20
Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites Jun 25
Aleafia Health Inc. Announces It Has Largely Completed Planting Across 86 Acres At Its Outdoor Cultivation Facility in Port Perry, Ont Jun 16
Aleafia Health Inc. Expands Trailblazing Wellness Brand Noon & Night with Launch of Freshly Minted Roll-On Jun 15
CFO & Corporate Secretary Benjamin Ferdinand has left the company Jun 12
Aleafia Health Inc.'s Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio Jun 11
First quarter 2021 earnings released: CA$0.036 loss per share (vs CA$0.022 loss in 1Q 2020) May 12
Aleafia Health Inc. Secures Health Canada Research Licence May 04
Full year 2020 earnings released: CA$0.85 loss per share (vs CA$0.18 loss in FY 2019) Mar 27
Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market Mar 17
Aleafia Health Inc. has completed a Composite Units Offering in the amount of CAD 19.92 million. Mar 11
Aleafia Health Inc. Launches THC Soft Chews Under its Edibles Brand Bogart’s Kitchen Mar 04
Aleafia Health Inc. to Report Q4, 2020 Results on Mar 25, 2021 Feb 26
Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity Feb 18
Aleafia Health Inc. Launches Sunday Market House of Brands Feb 12
New 90-day high: €0.59 Feb 06
Aleafia Health Inc. Announces Directorship Appointments Feb 02
Aleafia Health Announces Resignation Rhonda Lawson as Director Jan 31
Unifor and Aleafia Health Enter Exclusive Agreement to Support Medical Cannabis Coverage for Members Jan 22
Aleafia Health Inc. Enters Definitive Supply Agreement with Apipharm Jan 09
Unifor and Aleafia Health Inc. Partner on Groundbreaking Medical Cannabis Coverage Dec 20
New 90-day high: €0.38 Dec 18
Aleafia Health Enters into Supply Agreement with Robes Cannabis Inc Dec 18
Aleafia Health Launches High Potency CBD 50 Cannabis Oil Dec 06
Aleafia Health Inc. Launches Kin Slips® Rapid Onset Cannabis-Infused Sublingual Strips Nov 26
Third quarter 2020 earnings released: CA$0.066 loss per share Nov 12
Aleafia Health Inc. Announces Successful Outdoor Harvest Accelerates Product Portfolio Expansion Nov 07
Aleafia Health Inc. to Report Q3, 2020 Results on Nov 11, 2020 Oct 30
Aleafia Health Inc. Launches Cannabis 2.0 Portfolio with 510 Vape Cartridges Featuring Unique Formulations Sep 30
New 90-day low: €0.25 Sep 28
First half earnings released Aug 13
Aleafia Health Inc. to Report Q2, 2020 Results on Aug 12, 2020 Jul 17 Shareholder Returns ARAH DE Pharmaceuticals DE Market 7D 0% -0.2% -1.3% 1Y -50.8% -16.2% 14.9%
See full shareholder returns
Return vs Market: ARAH underperformed the German Market which returned 5.9% over the past year.
Price Volatility Is ARAH's price volatile compared to industry and market? ARAH volatility ARAH Average Weekly Movement n/a Pharmaceuticals Industry Average Movement 4.1% Market Average Movement 4.8% 10% most volatile stocks in DE Market 11.6% 10% least volatile stocks in DE Market 2.5%
Stable Share Price: ARAH's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ARAH's volatility change over the past year.
About the Company Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. The company owns and operates a virtual network of medical cannabis clinics staffed through physicians and nurse practitioners. Its product portfolio includes cannabis oils, capsules, edibles, cannabis-infused sublingual strips, pre-roll, milled, and vape cartridges; bath bombs and soft gels; hang dried, hand trimmed, long cured, and small batch dried flower; and concentrates.
Show more Aleafia Health Inc. Fundamentals Summary How do Aleafia Health's earnings and revenue compare to its market cap? ARAH fundamental statistics Market cap €5.48m Earnings (TTM ) -€23.53m Revenue (TTM ) €29.13m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) ARAH income statement (TTM ) Revenue CA$42.85m Cost of Revenue CA$36.85m Gross Profit CA$6.00m Other Expenses CA$40.61m Earnings -CA$34.61m
Last Reported Earnings
Mar 31, 2023
Earnings per share (EPS) -0.086 Gross Margin 14.00% Net Profit Margin -80.77% Debt/Equity Ratio -499.1%
How did ARAH perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2023/08/23 15:48 End of Day Share Price 2023/05/26 00:00 Earnings 2023/03/31 Annual Earnings 2023/03/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github .
Analyst Sources Aleafia Health Inc. is covered by 6 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Nikolaas Faes Bryan Garnier & Co Pablo Zuanic Cantor Fitzgerald & Co. Graeme Kreindler Eight Capital
Show 3 more analysts 
